Pelthos Therapeutics Appoints John M. Gay as Chief Financial Officer
Pelthos Therapeutics has announced the appointment of John M. Gay to the position of Chief Financial Officer, effective immediately.
Results for "Pelthos Therapeutics"
2 stories found
Pelthos Therapeutics Misses GAAP EPS, Beats Revenue Estimates in Q4
Pelthos Therapeutics reported a GAAP EPS of -$6.87, missing estimates, but its revenue of $9.39 million surpassed expectations for the quarter.